Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability
详细信息 查看全文
- 作者：Marcin Baranowski ; Agnieszka Blachnio-Zabielska ; Piotr Zabielski ; Jan Gorski
- 关键词：Diacylglycerol ; Heart ; High-fat diet ; Lipids ; PPAR ; Thiazolidinediones
- 刊名：Archives of Biochemistry and Biophysics
- 出版年：2008
- 出版时间：1 September 2008
- 年：2008
- 卷：477
- 期：1
- 页码：86-91
- 全文大小：468 K
文摘
Thiazolidinediones are insulin-sensitizing drugs which have been proved to be effective in the treatment of type 2 diabetes. However, the action of thiazolidinediones on myocardial metabolism is only poorly recognized. Therefore, the aim of our study was to investigate the effects of two-week pioglitazone treatment (3 mg/kg/d) on lipid and carbohydrate metabolism in the heart of rats fed on a standard chow or on a high-fat diet (HFD) for three weeks. High-fat feeding increased myocardial protein expression of all peroxisome proliferator-activated receptor (PPAR) isoforms. The greatest response was, however, noted in the case of PPARγ. Surprisingly, administration of pioglitazone induced accumulation of free fatty acids (FFA) and diacylglycerol in the heart in both groups, despite concomitant reduction in plasma FFA concentration. The content of triacylglycerol was increased only in the HFD group. Pioglitazone treatment also shifted myocardial substrate utilization towards greater contribution of glucose in both groups, as evidenced by decreased rate of palmitate oxidation and higher 2-deoxyglucose uptake and elevated glycogen content. This could induce a mismatch between the rate of myocardial fatty acid uptake and oxidation leading to increased intracellular availability of fatty acids for non-oxidative metabolic pathways like synthesis of acylglycerols. Our data suggests that thiazolidinediones improve cardiac insulin sensitivity by mechanisms other than reduction in intramyocardial lipid content.